Q4-FY26 · Dip Mewani
We consciously tightened credit terms in H1. We moderated sales growth and took short-term pain in favor of long-term financial discipline.
Aakaar Medical Technologies · tone and specificity signals across the available quarters.
Language signals
We consciously tightened credit terms in H1. We moderated sales growth and took short-term pain in favor of long-term financial discipline.
I want to keep our CAGR at 30% going forward. So I think we are on track.
If I want to put it in good parlance, Aakaar is Amazon of aesthetics in India.